Big Pharma faces tariff risks, patent cliffs, and regulatory pressure, but innovation and strong pipelines keep Eli Lilly, ...

Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock ...

Eli Lilly (LLY) concluded the recent trading session at $738.17, signifying a +1.51% move from its prior day's close.

Eli Lilly shares move past the 50-day SMA as weight-loss drug data, rising sales and pipeline momentum fuel optimism.

Thursday, August 28, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research ...

In the latest trading session, Eli Lilly (LLY) closed at $763.57, marking a +2.06% move from the previous day. The stock's change was more than the S&P 500's daily loss of 0.13%. Meanwhile, the Dow ...

Chicago, IL – September 3, 2025 – Today, Zacks Investment Ideas feature highlights Eli Lilly LLY, Eaton ETN and Interactive Brokers IBKR.

Investors closely monitor insider buys, as they can give hints surrounding the long-term picture. But it’s critical to note that insiders have a longer holding period than most, and many strict rules ...

AbbVie ABBV has gained 22.5% so far this year against a decrease of 0.1% for the industry. The stock has also outperformed ...